These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21169246)

  • 21. [Advances in cancer research. Cancer research and clinical oncology in the 21st century].
    Kanamaru R
    Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():3-7. PubMed ID: 10410653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The concept of ophthalmologic oncology development].
    Brovkina AF; Zarubeĭ GD; Val'skiĭ VV
    Vestn Oftalmol; 2000; 116(5):16-8. PubMed ID: 11221370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular diagnostic techniques in oncogenetics].
    Beroud C
    Ann Med Interne (Paris); 2001 Sep; 152(5):326-31. PubMed ID: 11593145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coming soon: a global grid for cancer research.
    Bouchie A
    Nat Biotechnol; 2004 Sep; 22(9):1071-3. PubMed ID: 15340462
    [No Abstract]   [Full Text] [Related]  

  • 25. Federal task force seeks standards for immunotherapy biomarker studies.
    Finkelstein JB
    J Natl Cancer Inst; 2009 May; 101(10):704-6. PubMed ID: 19436032
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative effectiveness research in oncology: the need for clarity, transparency and vision.
    Lyman GH
    Cancer Invest; 2009 Jul; 27(6):593-7. PubMed ID: 19557579
    [No Abstract]   [Full Text] [Related]  

  • 27. Endoscopic oncology: bridging the gap between gastroenterology and oncology.
    Lin JL; Barthel JS
    Gastroenterology; 2009 Aug; 137(2):741-2; author reply 742. PubMed ID: 19563836
    [No Abstract]   [Full Text] [Related]  

  • 28. [Non thermal plasmas, a new strategy in oncology?].
    Vandamme M; Robert E; Lerondel S; Pouvesle JM; Le Pape A
    Med Sci (Paris); 2012 Feb; 28(2):154-6. PubMed ID: 22377303
    [No Abstract]   [Full Text] [Related]  

  • 29. Targeted therapies: cui prodest?
    Ferrari D; Foa P
    J Clin Oncol; 2007 Oct; 25(29):4691-2; author reply 4692. PubMed ID: 17925568
    [No Abstract]   [Full Text] [Related]  

  • 30. Where adolescents and young adults with cancer receive their care: does it matter?
    Pollock BH
    J Clin Oncol; 2007 Oct; 25(29):4522-3. PubMed ID: 17925546
    [No Abstract]   [Full Text] [Related]  

  • 31. Personalized cancer therapy with selective kinase inhibitors: an emerging paradigm in medical oncology.
    McDermott U; Settleman J
    J Clin Oncol; 2009 Nov; 27(33):5650-9. PubMed ID: 19858389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The future of clinical cancer research in the next millennium.
    Freireich EJ
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2563-70. PubMed ID: 9815657
    [No Abstract]   [Full Text] [Related]  

  • 33. Phase 1 clinical trials in oncology.
    Muggia FM
    N Engl J Med; 2005 Jun; 352(23):2451-3; author reply 2451-3. PubMed ID: 15948269
    [No Abstract]   [Full Text] [Related]  

  • 34. [Current trends and potentials for the use of mathematical methods in oncology].
    Zherbin EA
    Vopr Onkol; 1984; 30(5):3-8. PubMed ID: 6730412
    [No Abstract]   [Full Text] [Related]  

  • 35. [Complementary Medicine in Oncology - difficult to claim effectiveness, quality and efficiency].
    Melchart D
    Forsch Komplementmed; 2015; 22(1):8-9. PubMed ID: 25824398
    [No Abstract]   [Full Text] [Related]  

  • 36. Response evaluation criteria in solid tumors (RECIST): new guidelines.
    Tsuchida Y; Therasse P
    Med Pediatr Oncol; 2001 Jul; 37(1):1-3. PubMed ID: 11466715
    [No Abstract]   [Full Text] [Related]  

  • 37. Moving toward individualized cancer therapies.
    Tonon G; Anderson KC
    Clin Cancer Res; 2008 Aug; 14(15):4682-4. PubMed ID: 18676734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hope for the future.
    Oliver DG
    Nurs Times; 1999 May 19-25; 95(20):27. PubMed ID: 10437511
    [No Abstract]   [Full Text] [Related]  

  • 39. Standardization of pathologic complete response rates in breast cancer treatment.
    Knauer M; Devries A; Wenzl E; Haid A
    Breast Cancer Res Treat; 2008 Jul; 110(2):395-6. PubMed ID: 17851755
    [No Abstract]   [Full Text] [Related]  

  • 40. C-Path: updating the art of pathology.
    Martin M
    J Natl Cancer Inst; 2012 Aug; 104(16):1202-4. PubMed ID: 22899628
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.